hepatitis c
Welcome to the 'hepatitis c' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'hepatitis c'.
Are you an expert about 'hepatitis c'? Do you want to be the Technorati authority on 'hepatitis c'? You can write a description that will appear right here:
Join Blogcritics!
Latest blogosphere posts tagged “hepatitis c”
-
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race
Xconomy —
Authority: 639
Luke Timmerman Vertex Pharmaceuticals went from king of the hill in the treatment of hepatitis C to yesterday’s news in about six wild months. But while many on Wall Street say Vertex’s big drug will soon become obsolete, Vertex and its small partner in South San Francisco have quietly put themselves in ...1 week ago -
MGDN (Video Update), BMY, LLL, RFX - Market Watch From PennyOmega.com!
CRWE NEWS Financial Stock Market Website —
Authority: 133
Medgenics, Inc. (NYSE Amex:MDGN), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announced that the Company received notice of ‘Intention to Grant’ from the European Patent Office for the patent application entitled ...1 week ago -
MDGN, BBT, CNW, PPG - CRWESelect.com Stock News! Medgenics Inc., BB&T Corporation, Con-Way Inc., PPG Industries Inc. (Video Included Inside)
CRWE NEWS Financial Stock Market Website —
Authority: 133
Medgenics, Inc. (AMEX: MDGN)MDGN announced that the Company received notice of ‘Intention to Grant’ from the European Patent Office for the patent application entitled “USE OF DERMAL MICRO ORGANS,” with allowed claims covering a core element of its Biopump™ protein therapy technology.“This patent is ...1 week ago -
Clarus Ventures Looks to Steer Ship Through Less Predictable Biotech Seas
Xconomy —
Authority: 639
Luke Timmerman It’s never been easy to make a buck in biotech venture capital, but there used to be more predictability and logic to it, according to Clarus Ventures’ Nick Galakatos . You’d invest a few million, or tens of millions, and push a new drug or device toward some scientific validation in a few ...1 week ago -
Hope for Hepatitis C
Now@NEJM: A Communications Blog —
Authority: 104
Imagine, for a moment, that you recently received a brand new Time-O-Matic Time Machine as a gift. How far back would you have to set the dial to see that meaningful progress has been made in the treatment of hepatitis C? First, let’s say you set the dial to January 2011 and –- Puff-kachunk! — you’re there. ...1 week ago -
New Combo KOs HCV Without Interferon, Ribavirin (CME/CE)
Health Fitness & Beauty - health-fitness.marc8.com —
Authority: 136
(MedPage Today) -- A combination of direct-acting antiviral agents aimed at hepatitis C -- and given without standard therapy -- can lead to sustained virologic response in patients with a difficult-to-treat strain of the virus.1 week ago -
Blood Transfusion Errors: Preventing Future Occurrences
noblood —
Authority: 107
Issue 10 - August 30, 1999 Blood Transfusion Errors: Preventing Future Occurrences August 30, 1999 Since the Joint Commission began tracking sentinel events more than three years ago, the Accreditation Committee of the Joint Commissions Board of Commissioners has reviewed 12 cases related to transfusion errors. For ...1 week ago -
Some Small Transfusions Pose Unnecessary Risks
noblood —
Authority: 107
January 17, 2012 — Medscape.com Surgeons should be extremely cautious with even minimal intraoperative transfusions because they can sicken and kill patients , researchers reported in an article published in the January issue of the Archives of Surgery. "Intraoperative transfusion of 1 unit of ...1 week ago -
Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy
Polygenicblog —
Authority: 123
Specific small hairpin RNAs can interfere with the replication of pathogenic viruses and are currently being tested as antiviral therapies in clinical trials: This paper identifies potent shRNAs for HIV , hepatitis C virus ( HCV ), and influenza. pub-57992245242643181 week ago -
New therapy could help beat Hepatitis C virus
Thaindian News —
Authority: 534
Toronto, Jan 17 (IANS) Scientists have found a way to block the Hepatitis C virus (HCV) and possibly benefit 170 million people worldwide.The breakthrough opens the way for new therapies to treat HCV which targets the liver and is among the leading causes of liver cancer and liver transplant globally. “Our approach ...2 weeks ago -
UBC researchers identify potential new therapy approach for hepatitis C
Polygenicblog —
Authority: 123
As HCV infects a person, it needs fat droplets in the liver to form new virus particles," says François Jean, Associate Professor in the Department of Microbiology and Immunology and Scientific Director of the Facility for Infectious Disease and Epidemic Research (FINDER) at UBC. "In the process, it causes fat ...2 weeks ago -
UBC researchers identify potential new therapy approach for hepa...
Health Fitness & Beauty - health-fitness.marc8.com —
Authority: 136
(University of British Columbia) Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus in the liver that could lead to new therapies for those affected by this and other infectious diseases.2 weeks ago -
TWiV 166: Breaking and entering
virology blog —
Authority: 479
Hosts: Vincent Racaniello , Dickson Despommier , Rich Condit , and Alan Dove Vincent, Dickson, Rich, and Alan review cell proteins essential for entry of hepatitis C, Ebola, and measles viruses. Please help us by taking our listener survey . Click the arrow above to play, or right-click to download TWiV ...2 weeks ago -
"Primum non Nocere / First, do no Harm" - Documentary Teaser
noblood —
Authority: 107
2 weeks ago -
Bristol To Acquire Inhibitex
Sports n Health —
Authority: 99
Bristol-Myers Squibb Co has agreed to acquire Inhibitex Inc for approximately $2.5 billion to gain access to its promising hepatitis C treatment , the companies said on Saturday. The deal at $26 per share is a huge 163 percent premium to Inhibitex’s closing price of $9.87 on Friday. The Bristol-Inhibitex deal ...2 weeks ago -
Bits and Pieces: Overwhelmed with Health Care at Day 12
Oh My Aches and Pains! —
Authority: 104
This new year is only 12 days old and I am already getting overwhelmed by all the health care tasks on my plate. Good grief! On Monday I shared about the flare-up that has followed me into this new year. Well, I went for a medical procedure Monday that only made it worse, yet again. I had no idea how much ...2 weeks ago -
Pharma Pays A Premium For Its Shopping Spree
Pharmalot —
Authority: 581
The recent price tags being paid for small drugmakers with Hepatitis C treatments underscore a growing trend that the pharmaceutical industry may find hard to avoid - huge premiums are being paid for select targets and drugmakers will be forced to continue to do so as they struggle to replenish their product ...2 weeks ago -
A couple that made winners | Hedge Funds/ Funds Management 2011
The Banking and Strategy Initiative —
Authority: 124
Bloomberg TV helped me a lot picking out the Top 4% of fund managers as Daniel Yachtman on Hedge Funds and Jim kieffer, announced Morning star stockpicker of the year made their appearance on the box, for your breakfast post, when you come back tomorrow. Stockpicking cash equities Various Financial stock ...2 weeks ago -
Ackman Plans A Proxy Fight, Todd Combs Posted Gain In Bershire, Chase Coleman Returned 45% In 2011
Insider Monkey —
Authority: 123
Ackman Canadian Pacific Proxy Fight Pivots On Ex-CEO’s Work At Rail Rival (Bloomberg) William Ackman’s plan to wage a proxy fight to install a new chief executive officer at... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]2 weeks ago -
Why Ive Decided to Treat My Hepatitis C Infection Now
Oh My Aches and Pains! —
Authority: 104
Hepatitis C is often called the dragon. I guess my new occupation is "dragon slayer." So today is THE big day. Today I go talk to my hepatologist about treating my chronic Hepatitis C infection. I admit I am feeling a whole bunch of things as I write this, from anxiety and fear to determination and courage. ...2 weeks ago


Follow Technorati